Aboul-Enein F, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Bruck W et al (2003) Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuropathol Exp Neurol 62:25–33. https://doi.org/10.1093/jnen/62.1.25
CAS
Article
PubMed
Google Scholar
Absinta M, Sati P, Masuzzo F, Nair G, Sethi V, Kolb H et al (2019) Association of chronic active multiple sclerosis lesions with disability in vivo. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2019.2399
Article
PubMed
PubMed Central
Google Scholar
Berger T, Rubner P, Schautzer F, Egg R, Ulmer H, Mayringer I et al (2003) Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 349:139–145. https://doi.org/10.1056/NEJMoa022328
CAS
Article
PubMed
Google Scholar
Breithaupt C, Schafer B, Pellkofer H, Huber R, Linington C, Jacob U (2008) Demyelinating myelin oligodendrocyte glycoprotein-specific autoantibody response is focused on one dominant conformational epitope region in rodents. J Immunol 181:1255–1263. https://doi.org/10.4049/jimmunol.181.2.1255
CAS
Article
PubMed
Google Scholar
Bruck W, Porada P, Poser S, Rieckmann P, Hanefeld F, Kretzschmar HA et al (1995) Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 38:788–796. https://doi.org/10.1002/ana.410380514
CAS
Article
PubMed
Google Scholar
Brunner C, Lassmann H, Waehneldt TV, Matthieu JM, Linington C (1989) Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats. J Neurochem 52:296–304. https://doi.org/10.1111/j.1471-4159.1989.tb10930.x
CAS
Article
PubMed
Google Scholar
Chen JJ, Flanagan EP, Jitprapaikulsan J, Lopez-Chiriboga ASS, Fryer JP, Leavitt JA et al (2018) Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol 195:8–15. https://doi.org/10.1016/j.ajo.2018.07.020
CAS
Article
PubMed
PubMed Central
Google Scholar
Cobo-Calvo A, d'Indy H, Ruiz A, Collongues N, Kremer L, Durand-Dubief F et al (2020) Frequency of myelin oligodendrocyte glycoprotein antibody in multiple sclerosis: a multicenter cross-sectional study. Neurol Neuroimmunol Neuroinflamm. https://doi.org/10.1212/NXI.0000000000000649
Article
PubMed
Google Scholar
Cobo-Calvo A, Ruiz A, Maillart E, Audoin B, Zephir H, Bourre B et al (2018) Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study. Neurology 90:e1858–e1869. https://doi.org/10.1212/WNL.0000000000005560
CAS
Article
PubMed
Google Scholar
Dal-Bianco A, Grabner G, Kronnerwetter C, Weber M, Hoftberger R, Berger T et al (2017) Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging. Acta Neuropathol 133:25–42. https://doi.org/10.1007/s00401-016-1636-z
CAS
Article
PubMed
Google Scholar
Dale RC, Tantsis EM, Merheb V, Kumaran RY, Sinmaz N, Pathmanandavel K et al (2014) Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton. Neurol Neuroimmunol Neuroinflamm 1:e12. https://doi.org/10.1212/NXI.0000000000000012
Article
PubMed
PubMed Central
Google Scholar
Di Pauli F, Berger T (2018) Myelin oligodendrocyte glycoprotein antibody-associated disorders: toward a new spectrum of inflammatory demyelinating CNS disorders? Front Immunol 9:2753. https://doi.org/10.3389/fimmu.2018.02753
CAS
Article
PubMed
PubMed Central
Google Scholar
Di Pauli F, Hoftberger R, Reindl M, Beer R, Rhomberg P, Schanda K et al (2015) Fulminant demyelinating encephalomyelitis: insights from antibody studies and neuropathology. Neurol Neuroimmunol Neuroinflamm 2:e175. https://doi.org/10.1212/NXI.0000000000000175
Article
PubMed
PubMed Central
Google Scholar
Dobson R, Ramagopalan S, Davis A, Giovannoni G (2013) Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. J Neurol Neurosurg Psychiatry 84:909–914. https://doi.org/10.1136/jnnp-2012-304695
Article
PubMed
Google Scholar
Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL et al (2018) Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2018.4053
Article
PubMed
PubMed Central
Google Scholar
Dyer CA, Matthieu JM (1994) Antibodies to myelin/oligodendrocyte-specific protein and myelin/oligodendrocyte glycoprotein signal distinct changes in the organization of cultured oligodendroglial membrane sheets. J Neurochem 62:777–787. https://doi.org/10.1046/j.1471-4159.1994.62020777.x
CAS
Article
PubMed
Google Scholar
Fischer MT, Wimmer I, Hoftberger R, Gerlach S, Haider L, Zrzavy T et al (2013) Disease-specific molecular events in cortical multiple sclerosis lesions. Brain 136:1799–1815. https://doi.org/10.1093/brain/awt110
Article
PubMed
PubMed Central
Google Scholar
Flach AC, Litke T, Strauss J, Haberl M, Gomez CC, Reindl M et al (2016) Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease. Proc Natl Acad Sci USA 113:3323–3328. https://doi.org/10.1073/pnas.1519608113
CAS
Article
PubMed
PubMed Central
Google Scholar
Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M et al (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132:1175–1189. https://doi.org/10.1093/brain/awp070
Article
PubMed
PubMed Central
Google Scholar
Frischer JM, Weigand SD, Guo Y, Kale N, Parisi JE, Pirko I et al (2015) Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol 78:710–721. https://doi.org/10.1002/ana.24497
Article
PubMed
PubMed Central
Google Scholar
Fujimori J, Takai Y, Nakashima I, Sato DK, Takahashi T, Kaneko K et al (2017) Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies. J Neurol Neurosurg Psychiatry 88:534–536. https://doi.org/10.1136/jnnp-2016-315094
Article
PubMed
Google Scholar
Hamid SHM, Whittam D, Saviour M, Alorainy A, Mutch K, Linaker S et al (2018) Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease. JAMA Neurol 75:65–71. https://doi.org/10.1001/jamaneurol.2017.3196
Article
PubMed
Google Scholar
Hennes EM, Baumann M, Schanda K, Anlar B, Bajer-Kornek B, Blaschek A et al (2017) Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Neurology 89:900–908. https://doi.org/10.1212/WNL.0000000000004312
CAS
Article
PubMed
Google Scholar
Hoftberger R, Sepulveda M, Armangue T, Blanco Y, Rostasy K, Calvo AC et al (2015) Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease. Mult Scler 21:866–874. https://doi.org/10.1177/1352458514555785
CAS
Article
PubMed
Google Scholar
Ikeda K, Kiyota N, Kuroda H, Sato DK, Nishiyama S, Takahashi T et al (2015) Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody. Mult Scler 21:656–659. https://doi.org/10.1177/1352458514551455
Article
PubMed
Google Scholar
Ikeda T, Yamada K, Ogawa R, Takai Y, Kaneko K, Misu T et al (2018) The pathological features of MOG antibody-positive cerebral cortical encephalitis as a new spectrum associated with MOG antibodies: a case report. J Neurol Sci 392:113–115. https://doi.org/10.1016/j.jns.2018.06.028
Article
PubMed
Google Scholar
Jarius S, Metz I, Konig FB, Ruprecht K, Reindl M, Paul F et al (2016) Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in ‘pattern II multiple sclerosis’ and brain biopsy findings in a MOG-IgG-positive case. Mult Scler 22:1541–1549. https://doi.org/10.1177/1352458515622986
CAS
Article
PubMed
Google Scholar
Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J et al (2018) MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation 15:134. https://doi.org/10.1186/s12974-018-1144-2
CAS
Article
PubMed
PubMed Central
Google Scholar
Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K et al (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J Neuroinflammation 13:279. https://doi.org/10.1186/s12974-016-0717-1
CAS
Article
PubMed
PubMed Central
Google Scholar
Jarius S, Ruprecht K, Stellmann JP, Huss A, Ayzenberg I, Willing A et al (2018) MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature. J Neuroinflammation 15:88. https://doi.org/10.1186/s12974-018-1108-6
CAS
Article
PubMed
PubMed Central
Google Scholar
Jitprapaikulsan J, Chen JJ, Flanagan EP, Tobin WO, Fryer JP, Weinshenker BG et al (2018) Aquaporin-4 and myelin oligodendrocyte glycoprotein autoantibody status predict outcome of recurrent optic neuritis. Ophthalmology 125:1628–1637. https://doi.org/10.1016/j.ophtha.2018.03.041
Article
PubMed
Google Scholar
Johns TG, Bernard CC (1999) The structure and function of myelin oligodendrocyte glycoprotein. J Neurochem 72:1–9
CAS
Article
PubMed
Google Scholar
Jurynczyk M, Geraldes R, Probert F, Woodhall MR, Waters P, Tackley G et al (2017) Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis. Brain 140:617–627. https://doi.org/10.1093/brain/aww350
Article
PubMed
Google Scholar
Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A et al (2017) Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain 140:3128–3138. https://doi.org/10.1093/brain/awx276
Article
PubMed
Google Scholar
Kortvelyessy P, Breu M, Pawlitzki M, Metz I, Heinze HJ, Matzke M et al (2017) ADEM-like presentation, anti-MOG antibodies, and MS pathology: two case reports. Neurol Neuroimmunol Neuroinflamm 4:e335. https://doi.org/10.1212/NXI.0000000000000335
Article
PubMed
PubMed Central
Google Scholar
Kuhlmann T, Ludwin S, Prat A, Antel J, Bruck W, Lassmann H (2017) An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol 133:13–24. https://doi.org/10.1007/s00401-016-1653-y
CAS
Article
PubMed
Google Scholar
Kunchok A, Chen JJ, McKeon A, Mills JR, Flanagan EP, Pittock SJ (2019) Coexistence of myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies in adult and pediatric patients. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2019.3656
Article
PubMed Central
Google Scholar
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452. https://doi.org/10.1212/wnl.33.11.1444
CAS
Article
PubMed
Google Scholar
Lang J, Biebl A, Gruber A, Maier-Hiebl B, Hainfellner JA, Hoftberger R et al (2018) Teaching Case 5–2018: integrated morphological and immunological work-up of neurosurgical specimen allows accurate diagnosis of neuroinflammatory lesions: an example of acute disseminated encephalomyelitis (ADEM) associated with anti-MOG antibodies. Clin Neuropathol 37:206–208. https://doi.org/10.5414/NP301136
Article
PubMed
PubMed Central
Google Scholar
Lassmann H (2005) Multiple sclerosis pathology: evolution of pathogenetic concepts. Brain Pathol 15:217–222. https://doi.org/10.1111/j.1750-3639.2005.tb00523.x
Article
PubMed
Google Scholar
Lassmann H, Brunner C, Bradl M, Linington C (1988) Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol 75:566–576. https://doi.org/10.1007/bf00686201
CAS
Article
PubMed
Google Scholar
Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473–477. https://doi.org/10.1084/jem.20050304
CAS
Article
PubMed
PubMed Central
Google Scholar
Linington C, Bradl M, Lassmann H, Brunner C, Vass K (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130:443–454
CAS
PubMed
PubMed Central
Google Scholar
Linington C, Lassmann H (1987) Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG). J Neuroimmunol 17:61–69. https://doi.org/10.1016/0165-5728(87)90031-2
CAS
Article
PubMed
Google Scholar
Lopez-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP et al (2018) Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders. JAMA Neurol 75:1355–1363. https://doi.org/10.1001/jamaneurol.2018.1814
Article
PubMed
PubMed Central
Google Scholar
Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707–717
CAS
Article
PubMed
Google Scholar
Lucchinetti CF, Popescu BF, Bunyan RF, Moll NM, Roemer SF, Lassmann H et al (2011) Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 365:2188–2197. https://doi.org/10.1056/NEJMoa1100648
CAS
Article
PubMed
PubMed Central
Google Scholar
Ludwin SK, Johnson ES (1981) Evidence for a "dying-back" gliopathy in demyelinating disease. Ann Neurol 9:301–305. https://doi.org/10.1002/ana.410090316
CAS
Article
PubMed
Google Scholar
Machado-Santos J, Saji E, Troscher AR, Paunovic M, Liblau R, Gabriely G et al (2018) The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells. Brain 141:2066–2082. https://doi.org/10.1093/brain/awy151
Article
PubMed
PubMed Central
Google Scholar
Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K et al (2011) Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflam 8:184. https://doi.org/10.1186/1742-2094-8-184
CAS
Article
Google Scholar
Mariotto S, Ferrari S, Monaco S, Benedetti MD, Schanda K, Alberti D et al (2017) Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study. J Neurol 264:2420–2430. https://doi.org/10.1007/s00415-017-8635-4
CAS
Article
PubMed
PubMed Central
Google Scholar
Moll NM, Rietsch AM, Ransohoff AJ, Cossoy MB, Huang D, Eichler FS et al (2008) Cortical demyelination in PML and MS: similarities and differences. Neurology 70:336–343. https://doi.org/10.1212/01.WNL.0000284601.54436.e4
CAS
Article
PubMed
Google Scholar
O'Connor KC, McLaughlin KA, De Jager PL, Chitnis T, Bettelli E, Xu C et al (2007) Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med 13:211–217. https://doi.org/10.1038/nm1488
CAS
Article
PubMed
PubMed Central
Google Scholar
Ogawa R, Nakashima I, Takahashi T, Kaneko K, Akaishi T, Takai Y et al (2017) MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy. Neurol Neuroimmunol Neuroinflamm 4:e322. https://doi.org/10.1212/NXI.0000000000000322
Article
PubMed
PubMed Central
Google Scholar
Peschl P, Bradl M, Hoftberger R, Berger T, Reindl M (2017) Myelin oligodendrocyte glycoprotein: deciphering a target in inflammatory demyelinating diseases. Front Immunol 8:529. https://doi.org/10.3389/fimmu.2017.00529
CAS
Article
PubMed
PubMed Central
Google Scholar
Piddlesden S, Lassmann H, Laffafian I, Morgan BP, Linington C (1991) Antibody-mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation. Clin Exp Immunol 83:245–250. https://doi.org/10.1111/j.1365-2249.1991.tb05622.x
CAS
Article
PubMed
PubMed Central
Google Scholar
Piddlesden SJ, Lassmann H, Zimprich F, Morgan BP, Linington C (1993) The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am J Pathol 143:555–564
CAS
PubMed
PubMed Central
Google Scholar
Popescu BF, Guo Y, Jentoft ME, Parisi JE, Lennon VA, Pittock SJ et al (2015) Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions. Neurology 84:148–158. https://doi.org/10.1212/WNL.0000000000001126
CAS
Article
PubMed
PubMed Central
Google Scholar
Popescu BF, Parisi JE, Cabrera-Gomez JA, Newell K, Mandler RN, Pittock SJ et al (2010) Absence of cortical demyelination in neuromyelitis optica. Neurology 75:2103–2109. https://doi.org/10.1212/WNL.0b013e318200d80c
Article
PubMed
PubMed Central
Google Scholar
Quek AM, McKeon A, Lennon VA, Mandrekar JN, Iorio R, Jiao Y et al (2012) Effects of age and sex on aquaporin-4 autoimmunity. Arch Neurol 69:1039–1043. https://doi.org/10.1001/archneurol.2012.249
Article
PubMed
PubMed Central
Google Scholar
Ramaglia V, Sheikh-Mohamed S, Legg K, Park C, Rojas OL, Zandee S et al (2019) Multiplexed imaging of immune cells in staged multiple sclerosis lesions by mass cytometry. Elife. https://doi.org/10.7554/eLife.48051
Article
PubMed
PubMed Central
Google Scholar
Ramanathan S, Mohammad S, Tantsis E, Nguyen TK, Merheb V, Fung VSC et al (2018) Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry 89:127–137. https://doi.org/10.1136/jnnp-2017-316880
Article
PubMed
Google Scholar
Reindl M, Waters P (2019) Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol 15:89–102. https://doi.org/10.1038/s41582-018-0112-x
CAS
Article
PubMed
Google Scholar
Saadoun S, Waters P, Owens GP, Bennett JL, Vincent A, Papadopoulos MC (2014) Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain. Acta Neuropathol Commun 2:35. https://doi.org/10.1186/2051-5960-2-35
Article
PubMed
PubMed Central
Google Scholar
Seifert T, Bauer J, Weissert R, Fazekas F, Storch MK (2007) Notch1 and its ligand Jagged1 are present in remyelination in a T-cell- and antibody-mediated model of inflammatory demyelination. Acta Neuropathol 113:195–203. https://doi.org/10.1007/s00401-006-0170-9
CAS
Article
PubMed
Google Scholar
Shu Y, Long Y, Wang S, Hu W, Zhou J, Xu H et al (2019) Brain histopathological study and prognosis in MOG antibody-associated demyelinating pseudotumor. Ann Clin Transl Neurol 6:392–396. https://doi.org/10.1002/acn3.712
CAS
Article
PubMed
PubMed Central
Google Scholar
Spadaro M, Gerdes LA, Mayer MC, Ertl-Wagner B, Laurent S, Krumbholz M et al (2015) Histopathology and clinical course of MOG-antibody-associated encephalomyelitis. Ann Clin Transl Neurol 2:295–301. https://doi.org/10.1002/acn3.164
CAS
Article
PubMed
PubMed Central
Google Scholar
Spadaro M, Winklmeier S, Beltran E, Macrini C, Hoftberger R, Schuh E et al (2018) Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein. Ann Neurol 84:315–328. https://doi.org/10.1002/ana.25291
CAS
Article
PubMed
Google Scholar
Storch MK, Bauer J, Linington C, Olsson T, Weissert R, Lassmann H (2006) Cortical demyelination can be modeled in specific rat models of autoimmune encephalomyelitis and is major histocompatibility complex (MHC) haplotype-related. J Neuropathol Exp Neurol 65:1137–1142. https://doi.org/10.1097/01.jnen.0000248547.13176.9d
CAS
Article
PubMed
Google Scholar
Storch MK, Stefferl A, Brehm U, Weissert R, Wallstrom E, Kerschensteiner M et al (1998) Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 8:681–694
CAS
Article
PubMed
Google Scholar
van Nierop GP, van Luijn MM, Michels SS, Melief MJ, Janssen M, Langerak AW et al (2017) Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients. Acta Neuropathol 134:383–401. https://doi.org/10.1007/s00401-017-1744-4
CAS
Article
PubMed
PubMed Central
Google Scholar
Vass K, Heininger K, Schafer B, Linington C, Lassmann H (1992) Interferon-gamma potentiates antibody-mediated demyelination in vivo. Ann Neurol 32:198–206. https://doi.org/10.1002/ana.410320212
CAS
Article
PubMed
Google Scholar
Vaughn CB, Jakimovski D, Kavak KS, Ramanathan M, Benedict RHB, Zivadinov R et al (2019) Epidemiology and treatment of multiple sclerosis in elderly populations. Nat Rev Neurol 15:329–342. https://doi.org/10.1038/s41582-019-0183-3
Article
PubMed
Google Scholar
Waldman A, Ness J, Pohl D, Simone IL, Anlar B, Amato MP et al (2016) Pediatric multiple sclerosis: clinical features and outcome. Neurology 87:S74–81. https://doi.org/10.1212/WNL.0000000000003028
Article
PubMed
Google Scholar
Wang JJ, Jaunmuktane Z, Mummery C, Brandner S, Leary S, Trip SA (2016) Inflammatory demyelination without astrocyte loss in MOG antibody-positive NMOSD. Neurology 87:229–231. https://doi.org/10.1212/WNL.0000000000002844
Article
PubMed
PubMed Central
Google Scholar
Waters P, Fadda G, Woodhall M, O'Mahony J, Brown RA, Castro DA et al (2019) Serial anti-myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2019.2940
Article
PubMed Central
Google Scholar
Waters PJ, Komorowski L, Woodhall M, Lederer S, Majed M, Fryer J et al (2019) A multicenter comparison of MOG-IgG cell-based assays. Neurology 92:e1250–e1255. https://doi.org/10.1212/WNL.0000000000007096
CAS
Article
PubMed
PubMed Central
Google Scholar
Weissert R, Wallstrom E, Storch MK, Stefferl A, Lorentzen J, Lassmann H et al (1998) MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest 102:1265–1273. https://doi.org/10.1172/JCI3022
CAS
Article
PubMed
PubMed Central
Google Scholar
Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177–189. https://doi.org/10.1212/WNL.0000000000001729
Article
PubMed
PubMed Central
Google Scholar
Young NP, Weinshenker BG, Lucchinetti CF (2008) Acute disseminated encephalomyelitis: current understanding and controversies. Semin Neurol 28:84–94. https://doi.org/10.1055/s-2007-1019130
Article
PubMed
Google Scholar
Young NP, Weinshenker BG, Parisi JE, Scheithauer B, Giannini C, Roemer SF et al (2010) Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain 133:333–348. https://doi.org/10.1093/brain/awp321
Article
PubMed
PubMed Central
Google Scholar
Zhou L, Huang Y, Li H, Fan J, Zhangbao J, Yu H et al (2017) MOG-antibody associated demyelinating disease of the CNS: a clinical and pathological study in Chinese Han patients. J Neuroimmunol 305:19–28. https://doi.org/10.1016/j.jneuroim.2017.01.007
CAS
Article
PubMed
Google Scholar